Alan Siems Law - 25 Aug 2026 Form 4 Insider Report for Park Dental Partners, Inc. (PARK)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Aug 2026, 14:18:53 UTC
Prior SEC filing
22 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Maxwell Black as Attorney-in-Fact for Alan Law

Key filing fact

Alan Siems Law filed Form 4 for Park Dental Partners, Inc. (PARK) on 25 Aug 2026.

Key facts

  • This page summarizes Alan Siems Law's Form 4 filing for Park Dental Partners, Inc. (PARK).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Aug 2026, 14:18.

Change

  • Previous filing in this sequence was filed on 22 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002089168 Primary reporting owner

Law Alan Siems

Relationship
Chief Clinical Officer - Specialty Practices, Director
Address
4633 CLARK AVENUE, WHITE BEAR LAKE
Signature
/s/ Maxwell Black as Attorney-in-Fact for Alan Law
Signature date
25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PARK transaction

Common Stock

Gift

Transaction value
Shares
-40
Change %
-0.02%
Price
Shares after
181,001
Date
25 Aug 2026
Ownership
Direct
Footnotes
F1
PARK transaction

Common Stock

Gift

Transaction value
Shares
-40
Change %
-0.02%
Price
Shares after
180,961
Date
25 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each reported transaction represents a bona fide gift of 40 shares to a separate individual for no consideration.

SEC remarks

Chief Clinical Officer - Specialty Practices

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .